BioArctic AB (BRCTF)
20.00
+6.34
(+46.45%)
USD |
OTCM |
Nov 14, 15:33
BioArctic Gross Profit Margin (Quarterly): 90.35% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 90.35% |
| March 31, 2024 | 92.46% |
| December 31, 2023 | -158.5% |
| September 30, 2023 | 92.60% |
| June 30, 2023 | 98.37% |
| March 31, 2023 | 96.45% |
| December 31, 2022 | -576.6% |
| September 30, 2022 | 85.85% |
| June 30, 2022 | -238.9% |
| March 31, 2022 | -299.4% |
| December 31, 2021 | -251.2% |
| September 30, 2021 | -251.3% |
| June 30, 2021 | -82.64% |
| March 31, 2021 | -57.43% |
| December 31, 2020 | -59.98% |
| September 30, 2020 | -1.09% |
| Date | Value |
|---|---|
| June 30, 2020 | -124.3% |
| March 31, 2020 | 71.22% |
| December 31, 2019 | 20.63% |
| September 30, 2019 | 34.62% |
| June 30, 2019 | 95.32% |
| March 31, 2019 | 52.77% |
| December 31, 2018 | 90.68% |
| September 30, 2018 | 54.56% |
| June 30, 2018 | 45.60% |
| March 31, 2018 | 50.03% |
| December 31, 2017 | 46.91% |
| September 30, 2017 | 59.78% |
| June 30, 2017 | 50.99% |
| March 31, 2017 | 98.98% |
| December 31, 2016 | 99.75% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-576.6%
Minimum
Dec 2022
98.37%
Maximum
Jun 2023
-76.50%
Average
-57.43%
Median
Mar 2021
Gross Profit Margin (Quarterly) Benchmarks
| Abliva AB | -- |
| Oncopeptides AB | -- |
| BioInvent International AB | -- |
| Hansa Biopharma AB | 76.62% |
| Camurus AB | 93.01% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.96% |
| Return on Assets | -7.89% |
| Return on Invested Capital | -8.96% |
| Profit Margin (Quarterly) | -137.3% |
| Operating Margin (Quarterly) | -152.2% |
| Return on Net Operating Assets | -50.06% |